MONAMI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.368
EU - Europa 4.051
AS - Asia 1.078
AF - Africa 34
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 13.535
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.346
RU - Federazione Russa 1.864
PL - Polonia 684
IE - Irlanda 525
IT - Italia 394
SE - Svezia 318
SG - Singapore 301
CN - Cina 293
HK - Hong Kong 232
IN - India 123
FI - Finlandia 77
JO - Giordania 69
DE - Germania 45
GB - Regno Unito 43
CH - Svizzera 35
CI - Costa d'Avorio 31
UA - Ucraina 30
TR - Turchia 28
CA - Canada 22
FR - Francia 12
VN - Vietnam 12
ES - Italia 10
NL - Olanda 9
JP - Giappone 8
KR - Corea 7
BE - Belgio 4
SC - Seychelles 3
IR - Iran 2
AU - Australia 1
BR - Brasile 1
CZ - Repubblica Ceca 1
EU - Europa 1
ID - Indonesia 1
IL - Israele 1
NZ - Nuova Zelanda 1
TW - Taiwan 1
Totale 13.535
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.887
Fairfield 1.096
Warsaw 684
Chandler 526
Dublin 524
Ashburn 496
Woodbridge 495
Seattle 476
Cambridge 412
Houston 371
Wilmington 339
Singapore 246
Lawrence 225
Altamura 224
Ann Arbor 192
Princeton 169
Moscow 143
Hong Kong 122
Mumbai 109
Beijing 101
Boston 97
San Diego 79
Boardman 75
Medford 63
Buffalo 60
Shanghai 52
Florence 50
Bern 33
Jacksonville 33
Kent 33
Abidjan 31
Falls Church 29
Izmir 26
Andover 22
Hillsboro 22
New York 22
Toronto 20
Los Angeles 17
Norwalk 17
Guangzhou 14
London 14
Dong Ket 12
Redmond 11
Redwood City 11
Yubileyny 10
Rome 8
Milan 7
Barcelona 6
Helsinki 6
Menlo Park 6
Rui'an 6
Bari 5
Turin 5
Brussels 4
Kilburn 4
Lappeenranta 4
Laurel 4
Phoenix 4
Tappahannock 4
West Jordan 4
Wuhan 4
Arezzo 3
Bologna 3
Bremen 3
Dearborn 3
Frankfurt am Main 3
Lawrenceville 3
Nanjing 3
Novara 3
Pune 3
Santeramo In Colle 3
Shenzhen 3
Vaiano 3
Bagno a Ripoli 2
Camaiore 2
College Park 2
Falkenstein 2
Fontebuona 2
Groningen 2
Inzai 2
Jinan 2
Las Palmas de Gran Canaria 2
Lexington 2
Littleton 2
Mahé 2
Maiori 2
Minneapolis 2
Montecalvo Irpino 2
Montréal 2
Munich 2
New Bedfont 2
Pisa 2
Prescot 2
Provaglio d'Iseo 2
Quanzhou 2
Salerno 2
San Floriano del Collio 2
San Giorgio a Cremano 2
San Mateo 2
Seoul 2
Totale 9.861
Salva come PNG Salva come JPEG
Nome #
Left ventricular cavity obliteration during dobutamine stress echocardiography in diabetic patients 263
Glucagon-Like Peptide-1, Diabetes, and Cognitive Decline: Possible Pathophysiological Links and Therapeutic Opportunities 241
Resistin level in coronary artery disease and heart failure: the central role of kidney function 239
Sulphonylureas and cancer: a case-control study. 225
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis. 202
A randomized, open-label, controlled trial to evaluate the antimicrobial and surgical effect of CO2 laser treatment in diabetic infected foot ulcers: DULCIS (diabetic ulcer, CO2 laser, and infections) study 137
Priapus is Happier with Venus than with Bacchus 135
Is obesity a further cardiovascular risk factor in patients with erectile dysfunction? 134
Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trials 130
DPP-4 inhibitors and lipids: Systematic review and meta-analysis 130
Alternative treatment or alternative to treatment? A systematic review of randomized trials on homeopathic preparations for diabetes and obesity 127
Low Testosterone is Associated with an Increased Risk of MACE Lethality in Subjects with Erectile Dysfunction 127
Toe amputations with SGLT-2 inhibitors: data from randomized clinical trials 124
Prolactin levels independently predict major cardiovascular events in patients with erectile dysfunction 118
Amphetamine derivatives and obesity 118
Targeting educational therapy for type 2 diabetes: Identification of predictors of therapeutic success 118
HbA1c levels and all-cause mortality in type 2 diabetic patients: Epidemiological evidence of the need for personalised therapeutic targets 118
Cardiovascular Safety of Incretin-Based Therapies in Type 2 Diabetes: Systematic Review of Integrated Analyses and Randomized Controlled Trials 115
Are psychopathological features relevant predictors of glucose control in patients with type 2 diabetes? A prospective study 115
Effects on lipid profile of dipeptidyl peptidase 4 inhibitors, pioglitazone, acarbose, and sulfonylureas: Meta-analysis of placebo-controlled trials 114
Adjustment of insulin doses when switching from glargine 100 U/ml or detemir to degludec: an observational study. 114
Back to glycemic control: An alternative look at the results of cardiovascular outcome trials in type 2 diabetes 114
Adjustment of insulin doses when switching from glargine 100 U/ml or detemir to degludec: an observational study 113
Impairment of couple relationship in male patients with sexual dysfunction is associated with overt hypogonadism. 112
Alpha-Tocopherol and contrast-induced nephropathy: a meta-analysis of randomized controlled trials 112
Failure to metformin and insulin secretagogue monotherapy: an observational cohort study. 111
All-cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanides. 111
Peripheral artery disease and amputations with Sodium-Glucose co-Transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials 111
Age and comorbidity in acute myocardial infarction: a report from the AMI-Florence Italian registry 111
Fasting and post-prandial glucose and diabetic complication. A meta-analysis 110
Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials 109
Severe Depressive Symptoms and Cardiovascular Risk in Subjects with Erectile Dysfunction 108
Bone Fractures with Sodium-Glucose Co-transporter-2 Inhibitors: How Real is the Risk? 108
Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study. 106
CO2 laser for the treatment of diabetic foot ulcers with exposed bone. A consecutive series of type 2 diabetic patients 105
Glomerular hyperfiltration and metabolic syndrome: results from the FIrenze-BAgno A Ripoli (FIBAR) Study 105
Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in Type 2 diabetic patients. 104
Dipeptidyl peptidase-4 inhibitors and bone fractures: A meta-analysis of randomized clinical trials 104
Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials 102
Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily 102
Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients. 101
Reply to Gaertner, K. and Frass, M 101
Effect of insulin secretagogues on major cardiovascular events and all-cause mortality: A meta-analysis of randomized controlled trials 101
Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials 101
Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients a retrospective cohort study. 100
Coronary artery disease screening in type II diabetic patients: Prognostic value of rest and stress echocardiography 99
Effects of PCSK9 inhibitors on LDL cholesterol, cardiovascular morbidity and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials 99
Deprescription in elderly patients with type 2 diabetes mellitus 99
Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials 99
Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials 99
Antimicrobial photodynamic therapy in infected diabetic foot ulcers: A multicenter preliminary experience 99
Impact of influenza vaccination on all-cause mortality and hospitalization for pneumonia in adults and the elderly with diabetes: A meta-analysis of observational studies 98
Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: A meta-analysis of randomized clinical trials 97
Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trials 97
Association between different screening strategies for SARS-CoV-2 and deaths and severe disease in Italy 97
Post-prandial glucose and diabetic complications: Systematic review of observational studies 96
Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials. 95
Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. 95
Periodontal disease and oral hygiene habits in a type 2 diabetic population 95
Potential Impact of Climate on Novel Corona Virus (COVID-19) Epidemic 95
Effects of SGLT-2 inhibitors on diabetic ketoacidosis: A meta-analysis of randomised controlled trials 95
Immune checkpoints inhibitors and hyperglycemia: A Meta-analysis of randomized controlled trials 95
All-cause and cardiovascular mortality in a consecutive series of patients with diabetic foot osteomyelitis 94
combined continuous glucose monitoring and subcutaneous insulin infusion versus self‐monitoring of blood glucose with optimized multiple injections in type 1 diabetes: A randomized cross‐over trial 94
Metabolic surgery for the treatment of type 2 diabetes: A network meta-analysis of randomized controlled trials 93
Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis. 93
Safety of dipeptidyl peptidase-4 inhibitors: A meta-analysis of randomized clinical trials 92
Rosiglitazone and cardiovascular risk. 90
Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials 89
Indexes of abdominal adiposity in patients with Type 2 diabetes 88
Low diastolic ambulatory blood pressure is associated with greater all-cause mortality in older patients with hypertension 88
Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials. 86
PCSK9 inhibitor therapy: A systematic review and meta-analysis of metabolic and cardiovascular outcomes in patients with diabetes 86
Is the evidence from clinical trials for cardiovascular risk or harm for glitazones convincing? 85
How many components for the metabolic syndrome? Results of exploratory factor analysis in the FIBAR study 85
Exploring the heterogeneity of the effects of SGLT-2 inhibitors in cardiovascular outcome trials 85
Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials 85
Metformin beyond diabetes: New life for an old drug 84
Type 1 diabetes and periodontitis: prevalence and periodontal destruction—a systematic review 84
National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study. 84
Short and medium-term efficacy of sodium glucose co-transporter-2 (SGLT-2) inhibitors: a meta-analysis of randomized clinical trials 84
Doses of insulin and its analogues and cancer occurence in insulin-treated type 2 diabetic patients. 82
Retrospective Matched Case-Control Study on the Use of CO2 Laser for the Treatment of Nonhealing Diabetic Foot Ulcers: The DULCIS-2 (Diabetic ULcer, CO2 Laser, and Infections) Study 82
All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials 82
Cholelithiasis in patientes treated with Glucagon-Like Peptide-1 Receptor: An updated meta-analysis of randomized controlled trials 80
Glucagon-like peptide-1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta-analysis and subgroup analysis of randomized controlled trials 79
Dypeptidylpeptidase-4 inhibitors and the cardiovascular system: How to manage the fil rouge 79
Pancreatitis and pancreatic cancer in patientes treated with Dipeptidyl Peptidase-4 inhibitors: An extensive and updated meta-analysis of randomized controlled trials 79
Direct-Acting antivirals for HCV treatment in older patients: a systematic review and meta-analysis 79
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials 79
Italian guidelines for the treatment of type 2 diabetes 79
Attending Diabetes Clinics is associated with a lower all-cause mortality. A meta-analysis of observational studies performed in Italy 78
Effects of glucagon-like peptide-1 receptor agonists on body weight: a meta-analysis. 78
Metabolic syndrome and cardiovascular mortality in older type 2 diabetic patients: a longitudinal study. 78
Efficacy and safety of degludec insulin: A meta-analysis of randomised trials 78
Use of an oxidized regenerated cellulose and collagen composite for healing of chronic diabetic foot ulcers: a report of two cases 78
Dipeptidyl peptidase-4 inhibitors in the elderly: More benefits or risks? 78
Inaccuracy in meta-analysis on rosiglitazone and myocardial infarction. 77
National Cholesterol Educational Program and International Diabetes Federation diagnostic criteria for metabolic syndrome in an Italian cohort: results from the FIBAR Study. 77
Glucagon-like peptide-1 and diabetes 2012. 77
Totale 10.523
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.258
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.258
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.334 0 0 0 0 0 255 241 248 234 157 137 62
2020/20211.205 91 129 162 88 45 94 114 89 112 116 95 70
2021/2022985 30 62 106 59 33 53 37 73 46 52 137 297
2022/20232.541 300 615 119 183 129 406 292 92 251 20 81 53
2023/2024880 42 92 152 47 54 76 44 172 22 85 62 32
2024/20254.661 219 733 449 1.042 2.042 176 0 0 0 0 0 0
Totale 13.679